Ascendiant Capital Markets Increases NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $46.00
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) had its price objective boosted by analysts at Ascendiant Capital Markets from $45.00 to $46.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. NRXP has been the topic of several other research reports. BTIG Research initiated coverage on NRx […]
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) had its price objective boosted by analysts at Ascendiant Capital Markets from $45.00 to $46.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. NRXP has been the topic of several other research reports. BTIG Research initiated coverage on NRx […]
